Lupin, Alkem Face 'Higher Risk' Of U.S. FDA Inspections, Cipla Least At Risk: Jefferies

Pharmaceutical product recalls in the three months ended March jumped to the highest in four quarters, according to Jefferies, raising the risk of inspections by the U.S. Food and Drug Administration. 10 product recalls from Alkem Laboratories Ltd., Alembic Pharma Ltd., Dr. Reddy’s Laboratories Ltd., Lupin Ltd., Sun Pharmaceutical Industries Ltd., and Zydus Cadila, have been reported in the January-March period, the research firm sai...